Chemoinformaics analysis of 2-Methyltetradecane
| Molecular Weight | 212.421 | nRot | 11 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 20 |
| Exact Molecular Weight | 212.25 | nRing | 0 |
| Solubility: LogS | -7.052 | nHRing | 0 |
| Solubility: LogP | 7.663 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 46.3874 |
| nHD | 0 | BPOL | 32.1026 |
| QED | 0.436 |
| Synth | 4.388 |
| Natural Product Likeliness | 2.681 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.341 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.756 |
| MDCK | 0.00000863 |
| BBB | 0.84 |
| PPB | 0.98314 |
| VDSS | 1.963 |
| FU | 0.0148474 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.491 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.958 |
| CYP2c9-inh | 0.096 |
| CYP2c9-sub | 0.314 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.409 |
| CYP3a4-inh | 0.202 |
| CYP3a4-sub | 0.784 |
| CL | 16.686 |
| T12 | 0.013 |
| hERG | 0.049 |
| Ames | 0.026 |
| ROA | 0.018 |
| SkinSen | 0.133 |
| Carcinogencity | 0.047 |
| EI | 0.01 |
| Respiratory | 0.536 |
| NR-Aromatase | 0.015 |
| Antiviral | Yes |
| Prediction | 0.741519 |